Difference between revisions of "Intraductal papilloma of the breast"

Jump to navigation Jump to search
no edit summary
Line 74: Line 74:
Features:<ref name=pmid22612506>{{Cite journal  | last1 = Furuya | first1 = C. | last2 = Kawano | first2 = H. | last3 = Yamanouchi | first3 = T. | last4 = Oga | first4 = A. | last5 = Ueda | first5 = J. | last6 = Takahashi | first6 = M. | title = Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ. | journal = Pathol Int | volume = 62 | issue = 6 | pages = 381-90 | month = Jun | year = 2012 | doi = 10.1111/j.1440-1827.2012.02811.x | PMID = 22612506 }}
Features:<ref name=pmid22612506>{{Cite journal  | last1 = Furuya | first1 = C. | last2 = Kawano | first2 = H. | last3 = Yamanouchi | first3 = T. | last4 = Oga | first4 = A. | last5 = Ueda | first5 = J. | last6 = Takahashi | first6 = M. | title = Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ. | journal = Pathol Int | volume = 62 | issue = 6 | pages = 381-90 | month = Jun | year = 2012 | doi = 10.1111/j.1440-1827.2012.02811.x | PMID = 22612506 }}
</ref>
</ref>
*CK5/6 +ve.  
*[[CK5/6]] +ve.  
*p63 +ve.
*[[p63]] +ve.
*MUC3 weak.
*MUC3 weak.
*ER weak.
*ER weak.
48,454

edits

Navigation menu